434 related articles for article (PubMed ID: 18981975)
21. Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.
Bauer M; Fairbanks L; Berghöfer A; Hierholzer J; Bschor T; Baethge C; Rasgon N; Sasse J; Whybrow PC
J Affect Disord; 2004 Dec; 83(2-3):183-90. PubMed ID: 15555712
[TBL] [Abstract][Full Text] [Related]
22. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
23. [The clinical and laboratory findings in Graves' multinodular type disease].
Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors of osteoporosis in female SLE patients-extended report.
Almehed K; Forsblad d'Elia H; Kvist G; Ohlsson C; Carlsten H
Rheumatology (Oxford); 2007 Jul; 46(7):1185-90. PubMed ID: 17500075
[TBL] [Abstract][Full Text] [Related]
25. Bone demineralization in postmenopausal women: role of anamnestic risk factors.
La Vignera S; Condorelli RA; Vicari E; Nicoletti C; Calogero AE
Int J Endocrinol; 2012; 2012():837187. PubMed ID: 22899918
[TBL] [Abstract][Full Text] [Related]
26. Related factors in bone mineral density of lumbal and femur in natural postmenopausal women.
Hassa H; Tanir HM; Senses T; Oge T; Sahin-Mutlu F
Arch Gynecol Obstet; 2005 Dec; 273(2):86-9. PubMed ID: 16001199
[TBL] [Abstract][Full Text] [Related]
27. Identification of the risk factors for osteoporosis among postmenopausal women.
Demir B; Haberal A; Geyik P; Baskan B; Ozturkoglu E; Karacay O; Deveci S
Maturitas; 2008; 60(3-4):253-6. PubMed ID: 18778903
[TBL] [Abstract][Full Text] [Related]
28. Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study.
Giusti M; Cecoli F; Fazzuoli L; De Franchis V; Ceresola E; Ferone D; Mussap M; Minuto F
Metabolism; 2007 May; 56(5):699-707. PubMed ID: 17445547
[TBL] [Abstract][Full Text] [Related]
29. [Importance of the clinical profile in the postmenopausal osteoporosis screening by densitometry].
Bigler JM; Abetel G; Krieg MA; Wimpfheimer C; Burnand B; Thiébaud D; Burckhardt P
Schweiz Med Wochenschr; 1996 Aug; 126(31-32):1347-51. PubMed ID: 8765376
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence and associated factors of osteoporosis among postmenopausal women in Chuncheon: Hallym Aging Study (HAS)].
Jang SN; Choi YH; Choi MG; Kang SH; Jeong JY; Choi YJ; Kim DH
J Prev Med Public Health; 2006 Sep; 39(5):389-96. PubMed ID: 17076179
[TBL] [Abstract][Full Text] [Related]
31. Is BMD testing appropriate for all menopausal women?
Kleerekoper M; Nelson DA
Int J Fertil Womens Med; 2005; 50(2):61-6. PubMed ID: 16334412
[TBL] [Abstract][Full Text] [Related]
32. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
Chen Z; Maricic M; Pettinger M; Ritenbaugh C; Lopez AM; Barad DH; Gass M; Leboff MS; Bassford TL
Cancer; 2005 Oct; 104(7):1520-30. PubMed ID: 16110508
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for postmenopausal osteoporosis: anthropometric measurements, age, age at menopause and the time elapsed after menopause onset.
Akdeniz N; Akpolat V; Kale A; Erdemoglu M; Kuyumcuoglu U; Celik Y
Gynecol Endocrinol; 2009 Feb; 25(2):125-9. PubMed ID: 19253109
[TBL] [Abstract][Full Text] [Related]
35. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O
J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
[TBL] [Abstract][Full Text] [Related]
36. The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment.
Eftekhari M; Asadollahi A; Beiki D; Izadyar S; Gholamrezanezhad A; Assadi M; Fard-Esfahani A; Fallahi B; Takavar A; Saghari M
Hell J Nucl Med; 2008; 11(3):160-3. PubMed ID: 19081859
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
Anaforoglu I; Nar-Demirer A; Bascil-Tutuncu N; Ertorer ME
J Diabetes Complications; 2009; 23(1):12-7. PubMed ID: 18413190
[TBL] [Abstract][Full Text] [Related]
38. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
Lupoli GA; Fittipaldi MR; Fonderico F; Panico A; Colarusso S; Di Micco L; Cavallo A; Costa L; Paglione A; Lupoli G
Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
[TBL] [Abstract][Full Text] [Related]
39. Serum prolidase activity in postmenopausal osteoporosis.
Namiduru ES; Binnur Erbagci A; Celik A; Yilmaz M; Tarakçioglu M
Minerva Med; 2007 Dec; 98(6):647-51. PubMed ID: 18299678
[TBL] [Abstract][Full Text] [Related]
40. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women.
Kim DJ; Khang YH; Koh JM; Shong YK; Kim GS
Clin Endocrinol (Oxf); 2006 Jan; 64(1):86-90. PubMed ID: 16402934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
